Hypoglycaemia presents a significant barrier to optimal diabetes management as fear of hypoglycaemic events may cause exaggerated avoidance behaviour and consequently sub-optimal insulin therapy and glycaemic control [11, 12]. The gene discussed is INS; the disease is diabetes mellitus.